Literature DB >> 9202956

Intratracheal aerosolization of endotoxin (LPS) in the rat: a comprehensive animal model to study adult (acute) respiratory distress syndrome.

H P van Helden1, W C Kuijpers, D Steenvoorden, C Go, P L Bruijnzeel, M van Eijk, H P Haagsman.   

Abstract

The aim of the study was to extend existing evidence that intratracheal aerosolization of LPS may serve as a very relevant model to study ARDS. The authors investigated the sequence of pathogenic events reflected by changes in levels of tumor necrosis factor alpha (TNF alpha), surfactant-associated protein A (SP-A) in BAL fluid, in addition to cell count, edema formation, and respiratory function. Within 24 h following intratracheal aerosolization of LPS in the rat, ARDS could be diagnosed according to the lung injury score for patients. This score includes the extent of the inflammatory density on chest X-rays, the severity of hypoxemia, the decline in lung compliance, and the level of PEEP (positive end expiratory pressure). In addition, other typical features of human ARDS appeared to be present in this model: (1) increased microvascular permeability reflected by edema, elevated levels of protein and of LDH, and increased numbers of PMNs in BAL fluid; (2) high levels of TNF alpha in BAL fluid preceding the appearance of PMNs; (3) changes in breathing pattern and a gradual development of respiratory failure with decreased compliance. SP-A levels in BAL fluid doubled within one hour after LPS administration, suggesting that this collectin may play a role in the immediate inflammatory response. Taken together, the findings presented here suggest that intratracheal LPS administration mimics the clinical development of ARDS very closely.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202956     DOI: 10.3109/01902149709039228

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  23 in total

1.  Time and dose-dependent impairment of neonatal respiratory motor activity after systemic inflammation.

Authors:  Nina R Morrison; Stephen M Johnson; Austin D Hocker; Rebecca S Kimyon; Jyoti J Watters; Adrianne G Huxtable
Journal:  Respir Physiol Neurobiol       Date:  2019-10-12       Impact factor: 1.931

2.  Hypoxia aggravates lipopolysaccharide-induced lung injury.

Authors:  D Vuichard; M T Ganter; R C Schimmer; D Suter; C Booy; L Reyes; T Pasch; B Beck-Schimmer
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

3.  The collagen receptor uPARAP/Endo180 regulates collectins through unique structural elements in its FNII domain.

Authors:  Kirstine Sandal Nørregaard; Oliver Krigslund; Niels Behrendt; Lars H Engelholm; Henrik Jessen Jürgensen
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

4.  PARP inhibitor, olaparib ameliorates acute lung and kidney injury upon intratracheal administration of LPS in mice.

Authors:  Kunal Kapoor; Esha Singla; Bijayani Sahu; Amarjit S Naura
Journal:  Mol Cell Biochem       Date:  2014-11-18       Impact factor: 3.396

5.  Lipopolysaccharide "two-hit" induced refractory hypoxemia acute respiratory distress model in rats.

Authors:  Yumei Li; Hongchang Wei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-08-07

6.  Ventilator-induced heat shock protein 70 and cytokine mRNA expression in a model of lipopolysaccharide-induced lung inflammation.

Authors:  Harriët A Vreugdenhil; Jack J Haitsma; Koos J Jansen; Jitske Zijlstra; Frans B Plötz; Jaap E van Dijk; Burkhard Lachmann; Hans van Vught; Cobi J Heijnen
Journal:  Intensive Care Med       Date:  2003-05-07       Impact factor: 17.440

7.  99MTc-Hexamethylpropyleneamine Oxime Imaging for Early Detection of Acute Lung Injury in Rats Exposed to Hyperoxia or Lipopolysaccharide Treatment.

Authors:  Said H Audi; Anne V Clough; Steven T Haworth; Meetha Medhora; Mahsa Ranji; John C Densmore; Elizabeth R Jacobs
Journal:  Shock       Date:  2016-10       Impact factor: 3.454

8.  Lipopolysaccharide pre-conditioning is protective in lung ischemia-reperfusion injury.

Authors:  Heather E Merry; Patrick S Wolf; Elizabeth Fitzsullivan; John C Keech; Michael S Mulligan
Journal:  J Heart Lung Transplant       Date:  2009-12-31       Impact factor: 10.247

9.  Anti-inflammatory and anticoagulative effects of paeonol on LPS-induced acute lung injury in rats.

Authors:  Pin-Kuei Fu; Chieh-Liang Wu; Tung-Hu Tsai; Ching-Liang Hsieh
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-21       Impact factor: 2.629

10.  Alterations in the human lung proteome with lipopolysaccharide.

Authors:  Russell P Bowler; Nichole Reisdorph; Richard Reisdorph; Edward Abraham
Journal:  BMC Pulm Med       Date:  2009-05-11       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.